Eminent NRI heart surgeon Dr Mukesh Hariawala to unveil 'revolutionary' cardiac technologies in India

Tuesday, 28/08/2012

http://in.news.yahoo.com/eminent-nri-heart-surgeon-dr-mukesh-hariawala-unveil-105333813.html

New Delhi, Aug 25 (ANI): Harvard trained, eminent Indian American Heart Surgeon and Research Scientist Dr Mukesh Hariawala will deliver the keynote lecture on receipt of this years prestigious " India's Most Admired Surgeon " award in Mumbai on 21st Sept, to be presented by Maharashtra Governor K Sankaranarayan.

The event will see the national launch of 3 new revolutionary cardiac technologies , Dr Hariawala's pioneering Triple Heart Therapy ( Angiogenesis + Stem Cells + Laser ) best done in a " Hybrid Operation Suite " , VAD ( Ventricular Assist Device ) and Non Invasive Shockwave Therapy in India.

The FDA or CE mark approved VAD's, which will be offered to patients as an alternative to Heart Transplantation, has a cumulative worldwide Implantations record which has crossed 10,000. The " Optimal VAD for India " would be one that has a good track record of reliability, minimal complications and competitive shelf price.

Elaborating on the long life lithium ion battery operated VAD's which plays the role of a Mechanical Artificial Heart, Dr Hariawala told ANI in an exclusive interview, that VAD is only for patients who are in advanced stage heart failure and who do not qualify as patients for routine angioplasty, stent or bypass surgery. VAD patients following implantation will be able to ambulate and begin enjoying an improved quality of life with certain restrictions, he said.

Storz Medical's unique " MODULITH - SLC Shock Wave " Non - Invasive system has an excellent record with CE certification that employs the principles of " Therapeutic Angiogenesis ". This easy to deliver technology is ultrasound image guided.

The controlled targeted level of shock wave energy stimulates the release of cellular growth factors like VEGF helping in formation of micro blood vessels from pre existing ones.

This resultant effect is provision of a large pool of oxygen rich collateral vessel network which supports circulation to the failing heart, thus giving early relief of angina related symptoms.

The advantage of this technology is negligible incidences of procedural complications, and is best suited for most Indian patients who have diabetes, diffused extensive non bypass-able coronary artery disease and who are in need of repeat bypass surgery but are high risk subjects . The well established EECP ( External Enhanced Counter Pulsation ) technology works on the same principle using inferior extremity cuffs.

Boston, US based Dr Mukesh Hariawala is also a Visiting Honorary Cardiac Surgeon at Mumbai's Jaslok Hospital. In addition to performing open heart surgery on many worldwide celebrities, Dr Hariawala along with Dr John Wright had performed the first Bypass operation in London on Prime Minister Dr Manmohan Singh in 1990.